TY - JOUR
T1 - A New Case Series Suggests That SCA48 (ATX/STUB1) Is Primarily a Monogenic Disorder
AU - van Prooije, Teije H.
AU - Pennings, Maartje
AU - Dorresteijn, Lucille
AU - Gardeitchik, Thatjana
AU - Odekerken, Vincent J.J.
AU - Oosterloo, Mayke
AU - Pedersen, Annie
AU - Verschuuren-Bemelmans, Corien C.
AU - Vrancken, Alexander
AU - Kamsteeg, Erik Jan
AU - van de Warrenburg, Bart P.C.
N1 - Funding Information:
TvP has nothing to declare. MP has nothing to declare. LD has received compensation for consultancy from AbbVie. TG has nothing to declare. VO has nothing to declare. MO submitted a patent application (EP23197746). AP has nothing to declare. CV\u2010B has nothing to declare. AV receives research support from ZE&GG/ZONMW (EXPRESS study). EK has nothing to declare. BvdW served as a consultant for Biogen, Biohaven Pharmaceuticals, VICO Therapeutics and has served on the Advisory boards of Biogen, VICO Therapeutics, Cure Rare Disease. He has received a speakers fee from MDC Malaysia and royalties from BSL\u2010Springer Nature. He receives research support from Hersenstichting, ZonMw, Dutch Scientific Organization, Christina Foundation.
Publisher Copyright:
© 2024 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
PY - 2024/1/1
Y1 - 2024/1/1
N2 - Background: Monoallelic, pathogenic STUB1 variants cause autosomal dominant cerebellar ataxia (ATX-STUB1/SCA48). Recently, a genetic interaction between STUB1 variants and intermediate or high-normal CAG/CAA repeats in TBP was suggested, indicating digenic inheritance or a disease-modifying role for TBP expansions. Objective: To determine the presence and impact of intermediate or high-normal TBP expansions in ataxic patients with heterozygous STUB1 variants. Methods: We describe 21 patients with ataxia carrying a heterozygous STUB1 variant and determined TBP repeat length. Results: A total of 15 of 21 patients (71%) carried a normal TBP<40 allele, 4 (19%) carried an intermediate TBP41–42 allele, and two carried a high-normal TBP40 allele (9.5%). Five of six carriers (83%) of both STUB1 variants and TBP40–42 alleles showed marked cognitive impairment. Conclusions: SCA48 is predominantly a monogenic disorder, because most patients carried an isolated, heterozygous STUB1 variant and presented with the typical combined phenotype of ataxia and cognitive dysfunction. Still, co-occurrence of TBP41–42 or high-normal TBP40 alleles was relatively frequent and associated with marked cognitive defects (28.5%), suggesting a modifying effect on clinical expression in some cases. © 2024 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
AB - Background: Monoallelic, pathogenic STUB1 variants cause autosomal dominant cerebellar ataxia (ATX-STUB1/SCA48). Recently, a genetic interaction between STUB1 variants and intermediate or high-normal CAG/CAA repeats in TBP was suggested, indicating digenic inheritance or a disease-modifying role for TBP expansions. Objective: To determine the presence and impact of intermediate or high-normal TBP expansions in ataxic patients with heterozygous STUB1 variants. Methods: We describe 21 patients with ataxia carrying a heterozygous STUB1 variant and determined TBP repeat length. Results: A total of 15 of 21 patients (71%) carried a normal TBP<40 allele, 4 (19%) carried an intermediate TBP41–42 allele, and two carried a high-normal TBP40 allele (9.5%). Five of six carriers (83%) of both STUB1 variants and TBP40–42 alleles showed marked cognitive impairment. Conclusions: SCA48 is predominantly a monogenic disorder, because most patients carried an isolated, heterozygous STUB1 variant and presented with the typical combined phenotype of ataxia and cognitive dysfunction. Still, co-occurrence of TBP41–42 or high-normal TBP40 alleles was relatively frequent and associated with marked cognitive defects (28.5%), suggesting a modifying effect on clinical expression in some cases. © 2024 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
KW - ataxia
KW - genetics
U2 - 10.1002/mds.29912
DO - 10.1002/mds.29912
M3 - Article
SN - 0885-3185
JO - Movement Disorders
JF - Movement Disorders
ER -